Summit Creek Advisors LLC cut its stake in Dolby Laboratories (NYSE:DLB – Free Report) by 8.9% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 113,846 shares of the electronics maker’s stock after selling 11,188 shares during the quarter. Summit Creek Advisors LLC owned 0.12% of Dolby Laboratories worth $7,311,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently modified their holdings of DLB. Hantz Financial Services Inc. increased its stake in shares of Dolby Laboratories by 166.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after acquiring an additional 220 shares during the last quarter. Rothschild Investment LLC increased its stake in shares of Dolby Laboratories by 4,046.7% in the 3rd quarter. Rothschild Investment LLC now owns 622 shares of the electronics maker’s stock valued at $45,000 after acquiring an additional 607 shares during the last quarter. Fifth Third Bancorp grew its position in shares of Dolby Laboratories by 34.7% in the 4th quarter. Fifth Third Bancorp now owns 746 shares of the electronics maker’s stock valued at $48,000 after purchasing an additional 192 shares during the period. Migdal Insurance & Financial Holdings Ltd. acquired a new position in shares of Dolby Laboratories in the 3rd quarter valued at approximately $50,000. Finally, Optiver Holding B.V. grew its position in shares of Dolby Laboratories by 7,955.6% in the 3rd quarter. Optiver Holding B.V. now owns 725 shares of the electronics maker’s stock valued at $52,000 after purchasing an additional 716 shares during the period. 58.56% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the company. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a research report on Friday, January 30th. Wall Street Zen lowered Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, January 31st. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, April 27th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and a consensus price target of $90.75.
Dolby Laboratories Stock Performance
Shares of DLB opened at $53.98 on Thursday. The stock has a 50 day simple moving average of $60.42 and a 200 day simple moving average of $63.50. Dolby Laboratories has a 52-week low of $52.45 and a 52-week high of $77.00. The firm has a market capitalization of $5.11 billion, a PE ratio of 21.34 and a beta of 0.86.
Dolby Laboratories (NYSE:DLB – Get Free Report) last released its earnings results on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, beating the consensus estimate of $1.31 by $0.06. The firm had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.34 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Equities research analysts predict that Dolby Laboratories will post 3.22 EPS for the current fiscal year.
Dolby Laboratories Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a $0.36 dividend. The ex-dividend date was Tuesday, May 12th. This represents a $1.44 annualized dividend and a yield of 2.7%. Dolby Laboratories’s payout ratio is presently 56.92%.
Insider Buying and Selling at Dolby Laboratories
In other Dolby Laboratories news, CFO Robert J. Park sold 4,895 shares of the business’s stock in a transaction that occurred on Tuesday, May 12th. The stock was sold at an average price of $56.68, for a total value of $277,448.60. Following the sale, the chief financial officer owned 81,490 shares in the company, valued at approximately $4,618,853.20. The trade was a 5.67% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, SVP John D. Couling sold 7,666 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The shares were sold at an average price of $57.55, for a total value of $441,178.30. Following the completion of the sale, the senior vice president owned 118,353 shares in the company, valued at $6,811,215.15. The trade was a 6.08% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 20,249 shares of company stock worth $1,157,434. Corporate insiders own 37.93% of the company’s stock.
Dolby Laboratories Company Profile
Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.
Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.
Read More
- Five stocks we like better than Dolby Laboratories
- TJX Companies Fires on All Cylinders With 9% Revenue Growth
- From Zepbound to Foundayo: Lilly’s Latest Results Support Oral GLP-1 Outlook
- AI Consolidation Begins: Blackstone & Google Forge an AI Empire
- USA Rare Earth Posts Strong Q1 2026 as Massive Serra Vera Deal Looms
Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLB – Free Report).
Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
